---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-123459"
form_type: "8-K"
ticker: "VREOF"
cik: "0001771706"
company_name: "Vireo Growth Inc."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:25:56.230915+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vireo Growth to acquire 17 Colorado dispensaries from PharmaCann for ~$49M in shares

## Summary
- Vireo enters APA to buy 17 Colorado dispensaries from PharmaCann; total consideration ~$49M in Vireo subordinate voting shares plus liability assumption.
- Deal expands Vireo's Colorado retail presence to 41 dispensaries; closing expected in 1H'26 subject to regulatory approvals.
- Management Services Agreement signed; Vireo subsidiary will operate the dispensaries through closing.
- Share consideration subject to adjustment based on inventory and payables; restricted under Canadian securities law and CSE.

## SEC filing metadata
- accession: 0001104659-25-123459
- form_type: 8-K
- ticker: VREOF
- cik: 0001771706
- company_name: Vireo Growth Inc.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1771706/000110465925123459/0001104659-25-123459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1771706/000110465925123459/tm2533764d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-123459
- JSON: https://secwatch.observer/filing/0001104659-25-123459.json
- Plain text: https://secwatch.observer/filing/0001104659-25-123459.txt

## Key facts
- Material Agreements
  Vireo Growth Inc. entered into APA with PharmaCann Inc., certain of PharmaCann's subsidiaries, and Argent Institutional Trust Company valued at $49,000,000.00 (effective 2025-12-16).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: PharmaCann Inc., certain of PharmaCann's subsidiaries, and Argent Institutional Trust Company
  - Value: $49,000,000.00
  - Effective: 2025-12-16
  source text: On December 16, 2025, Vireo Health, Inc. (“ Buyer ”), a Delaware corporation and wholly owned subsidiary of Vireo Growth Inc. (the “ Company ”), the Company, PharmaCann Inc., a Delaware corporation (“ PharmaCann ”), certain of PharmaCann’s subsidiaries (collectively, with PharmaCann the “ Seller Parties ”), and Argent Institutional Trust Company (“ Agent ”), as collateral agent under the Indenture, dated as of June 24, 2021, by and among PharmaCann, as issuer, the Guarantors (as defined thereunder) party thereto, including the Seller Parties, and Agent, as trustee and collateral agent thereunder, entered into an Asset Purchase Agreement (the “ APA ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1771706/000110465925123459/0001104659-25-123459-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.